Literature DB >> 24625379

An introduction to patient-reported outcome measures in ophthalmic research.

A K Denniston1, D Kyte2, M Calvert3, J M Burr4.   

Abstract

Clinical outcomes, such as quantifying the extent of visual field loss by automated perimetry, are valued highly by health professionals, but such measures do not capture the impact of the condition on a patient's life. Patient-reported outcomes describe any report or measure of health reported by the patient, without external interpretation by a clinician or researcher. In this review, we discuss the value of the measures that capture this information (patient-reported outcome measures; PROMs), and why they are important to both the clinician and the researcher. We also consider issues around developing or selecting a PROM for ophthalmic research, the emerging challenges around conducting and reporting PROMs in clinical trials and highlight best practice for their use. Search terms for this review comprised: (1) (patient-reported outcomes OR patient-reported outcome measures) AND (2) randomised controlled trials AND (3) limited to ophthalmic conditions. These terms were expanded as follows: ((('patients'(MeSH Terms) OR 'patients'(All Fields) OR 'patient'(All Fields)) AND ('research report'(MeSH Terms) OR ('research'(All Fields) AND 'report'(All Fields)) OR 'research report'(All Fields) OR 'reported'(All Fields)) AND outcomes(All Fields)) OR (('patients'(MeSH Terms) OR 'patients'(All Fields) OR 'patient'(All Fields)) AND ('research report'(MeSH Terms) OR ('research'(All Fields) AND 'report'(All Fields)) OR 'research report'(All Fields) OR 'reported'(All Fields) AND ('outcome assessment (health care)'(MeSH Terms) OR ('outcome'(All Fields) AND 'assessment'(All Fields) AND '(health'(All Fields) AND 'care)'(All Fields)) OR 'outcome assessment (health care)'(All Fields) OR ('outcome'(All Fields) AND 'measures'(All Fields)) OR 'outcome measures'(All Fields)))) AND ('randomized controlled trial'(Publication Type) OR 'randomized controlled trials as topic'(MeSH Terms) OR 'randomised controlled trials'(All Fields) OR 'randomized controlled trials'(All Fields)) AND (ophth*(All Fields)). The authors also utilised the extensive non-ophthalmic literature and online resources relating to PROs and PROMs to inform this review.

Entities:  

Mesh:

Year:  2014        PMID: 24625379      PMCID: PMC4058607          DOI: 10.1038/eye.2014.41

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  47 in total

1.  Remediating serious flaws in the National Eye Institute Visual Function Questionnaire.

Authors:  Konrad Pesudovs; Vijaya K Gothwal; Thomas Wright; Ecosse L Lamoureux
Journal:  J Cataract Refract Surg       Date:  2010-05       Impact factor: 3.351

Review 2.  Evaluating patient-based outcome measures for use in clinical trials.

Authors:  R Fitzpatrick; C Davey; M J Buxton; D R Jones
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

3.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

4.  Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system.

Authors:  M A Testa; N K Hollenberg; R B Anderson; G H Williams
Journal:  Am J Hypertens       Date:  1991-04       Impact factor: 2.689

5.  Reliability and validity of the Ocular Surface Disease Index.

Authors:  R M Schiffman; M D Christianson; G Jacobsen; J D Hirsch; B L Reis
Journal:  Arch Ophthalmol       Date:  2000-05

6.  Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.

Authors:  David M Brown; Jeffrey S Heier; W Lloyd Clark; David S Boyer; Robert Vitti; Alyson J Berliner; Oliver Zeitz; Rupert Sandbrink; Xiaoping Zhu; Julia A Haller
Journal:  Am J Ophthalmol       Date:  2012-12-04       Impact factor: 5.258

7.  Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.

Authors:  Usha Chakravarthy; Simon P Harding; Chris A Rogers; Susan M Downes; Andrew J Lotery; Lucy A Culliford; Barnaby C Reeves
Journal:  Lancet       Date:  2013-07-19       Impact factor: 79.321

8.  Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitis.

Authors:  Susan Lightman; Rubens Belfort; Rupali K Naik; Careen Lowder; C Stephen Foster; Anne M Rentz; Harry Cui; Scott M Whitcup; Jonathan W Kowalski; Dennis A Revicki
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-18       Impact factor: 4.799

Review 9.  Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review.

Authors:  Derek G Kyte; Heather Draper; Jonathan Ives; Clive Liles; Adrian Gheorghe; Melanie Calvert
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

10.  Potential of patient-reported outcomes as nonprimary endpoints in clinical trials.

Authors:  Ari Gnanasakthy; Sandra Lewis; Marci Clark; Margaret Mordin; Carla DeMuro
Journal:  Health Qual Life Outcomes       Date:  2013-05-15       Impact factor: 3.186

View more
  14 in total

1.  What Is the Value of Preference Values for Patient-Centered Eye Care?

Authors:  Joshua R Ehrlich
Journal:  JAMA Ophthalmol       Date:  2018-06-01       Impact factor: 7.389

2.  Patient-Reported Outcomes After Corneal Transplantation.

Authors:  Grace E Dunbar; Michael Titus; Joshua D Stein; Tomas E Meijome; Shahzad I Mian; Maria A Woodward
Journal:  Cornea       Date:  2021-10-01       Impact factor: 3.152

Review 3.  Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis.

Authors:  Alastair K Denniston; Gary N Holland; Andrej Kidess; Robert B Nussenblatt; Annabelle A Okada; James T Rosenbaum; Andrew D Dick
Journal:  Orphanet J Rare Dis       Date:  2015-08-19       Impact factor: 4.123

4.  Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study.

Authors:  Winfried M Amoaku; Richard P Gale; Andrew J Lotery; Geeta Menon; Sobha Sivaprasad; Jennifer Petrillo; Jennifer Quinn
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 5.  "The patient is speaking": discovering the patient voice in ophthalmology.

Authors:  Samera Dean; Jonathan M Mathers; Melanie Calvert; Derek G Kyte; Dolores Conroy; Annie Folkard; Sue Southworth; Philip I Murray; Alastair K Denniston
Journal:  Br J Ophthalmol       Date:  2017-04-28       Impact factor: 4.638

Review 6.  Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature.

Authors:  Benedicte Lescrauwaet; Koenraad Blot; Timothy L Jackson
Journal:  Patient Relat Outcome Meas       Date:  2019-03-27

7.  Refinement and preliminary evaluation of two tablet-based tests of real-world visual function.

Authors:  Pete R Jones; Iris Tigchelaar; Giorgia Demaria; Iain Wilson; Wei Bi; Deanna J Taylor; David P Crabb
Journal:  Ophthalmic Physiol Opt       Date:  2020-01       Impact factor: 3.117

8.  A preliminary investigation examining patient reported outcome measures for low back pain and utilisation amongst chiropractors in Australia: facilitators and barriers to clinical implementation.

Authors:  Natalie Clohesy; Anthony Schneiders
Journal:  Chiropr Man Therap       Date:  2018-10-09

9.  Outcomes in patients with chronic uveitis: which factors matter to patients? A qualitative study.

Authors:  Aline C Stolk-Vos; Hamasa Kasigar; Karlijn J Nijmeijer; Tom O Missotten; Jan J Busschbach; Joris J van de Klundert; Leonieke W Kranenburg
Journal:  BMC Ophthalmol       Date:  2020-03-30       Impact factor: 2.209

10.  Patient-reported outcome measures in ophthalmology: too difficult to read?

Authors:  Deanna J Taylor; Lee Jones; Laura Edwards; David P Crabb
Journal:  BMJ Open Ophthalmol       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.